Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

NCT04090034 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumor

Interventions

PROCEDURE: Peptide Receptor Radionuclide Therapy

Sponsor

Methodist Health System